Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021

Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021

Abstract Background Artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) are the currently recommended first- and second-line therapies for uncomplicated Plasmodium falciparum infections in Togo. This study assessed the efficacy of these combinations, the proportion of Day3-positive...

Full description

Bibliographic Details
Main Authors: Ameyo Monique Dorkenoo, Marian Warsame, Essoham Ataba, Manani Hemou, Kossi Yakpa, Efoe Sossou, M’badi Mitigmsagou, Carmel Diwaba Teou, Emmanuelle Caspar, Laurence Ma, Koffi Edem Djadou, Tinah Atcha-Oubou, Charlotte Rasmussen, Didier Menard
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Malaria Journal
Subjects:
Artemether-lumefantrine
Dihydroartemisinin-piperaquine
Plasmodium falciparum
Efficacy
Molecular markers of antimalarial drug resistance
Togo
Online Access:https://doi.org/10.1186/s12936-024-04922-1

Internet

https://doi.org/10.1186/s12936-024-04922-1

Similar Items